Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.02
+2.0%
$0.96
$0.87
$1.72
$390.37M1.323.30 million shs1.14 million shs
MDxHealth SA stock logo
MDXH
MDxHealth
$2.00
-0.5%
$2.64
$1.70
$5.33
$99.49M1.6164,225 shs68,673 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.15
-4.6%
$4.84
$2.59
$5.70
$369.83M1.0195,513 shs205,095 shs
TruBridge, Inc. stock logo
TBRG
TruBridge
$25.83
+0.2%
$19.44
$13.88
$26.68
$386.68M1.3545,041 shs143,921 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Standard BioTools Inc. stock logo
LAB
Standard BioTools
0.00%+7.68%+6.75%-20.63%-1.48%
MDxHealth SA stock logo
MDXH
MDxHealth
0.00%-1.47%-1.95%-43.06%+18.24%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
0.00%+3.45%+11.11%+12.50%+80.00%
TruBridge, Inc. stock logo
TBRG
TruBridge
0.00%+0.31%+47.15%+27.31%+1.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$1.02
+2.0%
$0.96
$0.87
$1.72
$390.37M1.323.30 million shs1.14 million shs
MDxHealth SA stock logo
MDXH
MDxHealth
$2.00
-0.5%
$2.64
$1.70
$5.33
$99.49M1.6164,225 shs68,673 shs
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$5.15
-4.6%
$4.84
$2.59
$5.70
$369.83M1.0195,513 shs205,095 shs
TruBridge, Inc. stock logo
TBRG
TruBridge
$25.83
+0.2%
$19.44
$13.88
$26.68
$386.68M1.3545,041 shs143,921 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Standard BioTools Inc. stock logo
LAB
Standard BioTools
0.00%+7.68%+6.75%-20.63%-1.48%
MDxHealth SA stock logo
MDXH
MDxHealth
0.00%-1.47%-1.95%-43.06%+18.24%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
0.00%+3.45%+11.11%+12.50%+80.00%
TruBridge, Inc. stock logo
TBRG
TruBridge
0.00%+0.31%+47.15%+27.31%+1.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Standard BioTools Inc. stock logo
LAB
Standard BioTools
1.67
Reduce$1.3532.35% Upside
MDxHealth SA stock logo
MDXH
MDxHealth
2.60
Moderate Buy$7.75287.50% Upside
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
2.33
Hold$7.5045.63% Upside
TruBridge, Inc. stock logo
TBRG
TruBridge
2.13
Hold$23.95-7.28% Downside

Current Analyst Ratings Breakdown

Latest MDXH, TBRG, LAB, and SOPH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/6/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingBuy$8.00
4/27/2026
TruBridge, Inc. stock logo
TBRG
TruBridge
Reiterated RatingHold$26.25
4/24/2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
UpgradeSell (E+)Sell (D-)
4/24/2026
TruBridge, Inc. stock logo
TBRG
TruBridge
Reiterated RatingMarket Perform$26.25
4/24/2026
TruBridge, Inc. stock logo
TBRG
TruBridge
DowngradeStrong-BuyHold
4/23/2026
TruBridge, Inc. stock logo
TBRG
TruBridge
DowngradeOverweightNeutral$25.00 ➝ $26.25
4/21/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Reiterated RatingSell (D-)
4/15/2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
Boost Price TargetBuy$7.00 ➝ $8.00
4/6/2026
TruBridge, Inc. stock logo
TBRG
TruBridge
UpgradeHoldStrong-Buy
4/1/2026
TruBridge, Inc. stock logo
TBRG
TruBridge
Lower Price TargetEqual Weight$20.00 ➝ $18.00
3/27/2026
MDxHealth SA stock logo
MDXH
MDxHealth
Reiterated RatingSell (D-)
(Data available from 5/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$85.33M4.67N/AN/A$1.44 per share0.71
MDxHealth SA stock logo
MDXH
MDxHealth
$107.88M0.92N/AN/A($0.24) per share-8.33
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
$77.27M4.56N/AN/A$0.67 per share7.69
TruBridge, Inc. stock logo
TBRG
TruBridge
$346.84M1.12$3.83 per share6.74$11.86 per share2.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.90M$0.205.10N/AN/A73.46%-8.18%-6.43%N/A
MDxHealth SA stock logo
MDXH
MDxHealth
-$33.52M-$0.67N/AN/AN/A-31.07%-1,078.01%-21.71%5/13/2026 (Estimated)
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$79M-$0.52N/AN/AN/A-44.48%-62.74%-21.85%N/A
TruBridge, Inc. stock logo
TBRG
TruBridge
$4.21M$0.20129.1512.422.210.90%17.32%7.67%N/A

Latest MDXH, TBRG, LAB, and SOPH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026
MDxHealth SA stock logo
MDXH
MDxHealth
-$0.1447N/AN/AN/A$30.89 millionN/A
5/5/2026Q1 2026
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.2325-$0.27-$0.0375-$0.27$20.40 million$21.69 million
3/3/2026Q4 2025
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
-$0.20-$0.28-$0.08-$0.28$21.20 million$21.71 million
2/27/2026Q4 2025
MDxHealth SA stock logo
MDXH
MDxHealth
-$0.13-$0.17-$0.04-$0.17$26.05 million$29.55 million
2/24/2026Q4 2025
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.03$0.05+$0.08$0.05$18.50 million$23.80 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
MDxHealth SA stock logo
MDXH
MDxHealth
N/AN/AN/AN/AN/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
N/AN/AN/AN/AN/A
TruBridge, Inc. stock logo
TBRG
TruBridge
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
12.36
4.01
MDxHealth SA stock logo
MDXH
MDxHealth
N/A
1.08
0.94
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
1.05
2.06
1.84
TruBridge, Inc. stock logo
TBRG
TruBridge
0.91
1.81
1.79

Institutional Ownership

CompanyInstitutional Ownership
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
MDxHealth SA stock logo
MDXH
MDxHealth
N/A
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
31.59%
TruBridge, Inc. stock logo
TBRG
TruBridge
88.64%

Insider Ownership

CompanyInsider Ownership
Standard BioTools Inc. stock logo
LAB
Standard BioTools
23.16%
MDxHealth SA stock logo
MDXH
MDxHealth
1.70%
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
4.88%
TruBridge, Inc. stock logo
TBRG
TruBridge
10.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
620390.37 million299.96 millionOptionable
MDxHealth SA stock logo
MDXH
MDxHealth
30049.50 million48.66 millionNot Optionable
SOPHiA GENETICS SA stock logo
SOPH
SOPHiA GENETICS
52068.49 million65.14 millionNot Optionable
TruBridge, Inc. stock logo
TBRG
TruBridge
3,50015.00 million13.39 millionOptionable

Recent News About These Companies

TruBridge (TBRG) Surpasses Q1 Earnings Estimates
TruBridge Announces First Quarter 2026 Results
TruBridge (TBRG) to Release Earnings on Wednesday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$1.02 +0.02 (+2.00%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$1.01 -0.01 (-0.49%)
As of 05/8/2026 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

MDxHealth stock logo

MDxHealth NASDAQ:MDXH

$2.00 -0.01 (-0.50%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$2.00 +0.00 (+0.25%)
As of 05/8/2026 04:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection. The company offers genomic prostate score which provides personalized genomic insights to both physicians and patients navigating the complexities of prostate cancer diagnosis and treatment. It sells its products through urology sales force, consisting of direct sales representatives, strategic account managers, and regional sales managers. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

SOPHiA GENETICS stock logo

SOPHiA GENETICS NASDAQ:SOPH

$5.15 -0.25 (-4.63%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$4.98 -0.17 (-3.30%)
As of 05/8/2026 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

TruBridge stock logo

TruBridge NASDAQ:TBRG

$25.83 +0.05 (+0.19%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$25.84 +0.01 (+0.04%)
As of 05/8/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

TruBridge, Inc. provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence. The company provides acute care solutions and related services for community hospitals, and physician clinics; and patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. In addition, it offers patient liability estimates eligibility verification, claim scrubbing and submission, remittance management, denial/audit management, and contract management; and offers RCM services, such as accounts receivable management, private pay service, medical coding, revenue cycle consulting, and other additional insurance and patient billing services. Further, it offers consulting and business management services; managed IT services; encoder solutions; patient management; financial accounting; clinical; patient care; and enterprise applications. Additionally, it offers TruBridge HER platform, including total system support, national client conference, continuing education, software releases, hardware replacement, cloud electronic health record, forms and supplies, and public cloud infrastructure services; post-acute care software systems, and support and maintenance services; and InstantPHR, an interactive portal and CHBase which funnels data from multiple sources into one platform. The company was formerly known as Computer Programs and Systems, Inc. and changed its name to TruBridge, Inc. in March 2024. TruBridge, Inc. was founded in 1979 and is headquartered in Mobile, Alabama.